Clinical Research Directory
Browse clinical research sites, groups, and studies.
Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO
Sponsor: Xiaotong Hou
Summary
The purpose of this study is to evaluate the effectiveness and safety of nafamostat mesilate compared with unfractionated heparin for anticoagulation in patients with ECMO after cardiac surgery.
Official title: Use of Nafamostat Mesilate for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation After Cardiac Surgery: Efficacy and Safety
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-07-01
Completion Date
2026-12-31
Last Updated
2025-09-25
Healthy Volunteers
No
Interventions
nafamostat mesilate
Use nafamostat mesilate as an anticoagulant
unfractionated heparin group
Use unfractionated heparin as an anticoagulant
Locations (1)
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China